Difficulty: Medium
Average Score: 69%
Practice
Indication for 1,25-dihydroxyvitamin D3 (calcitriol) administration is:
Correct answer
A
Rationale
In this question, the correct answer is A) Vitamin D resistance.
1,25-dihydroxyvitamin D3 (calcitriol) is the active form of vitamin D in the body. Administering calcitriol is indicated in cases of vitamin D resistance, where the body is unable to respond effectively to vitamin D. By providing the active form directly, the body can bypass the resistance and still utilize vitamin D for its various functions, such as calcium absorption in the gut and bone health.
Now, let's analyze why the other options are incorrect:
B) Elevated skeletal turnover: This is not an indication for administering calcitriol. Elevated skeletal turnover may be seen in conditions like osteoporosis, but calcitriol is not the primary treatment for this.
C) Hypercalcemia of malignancy: Administering calcitriol in hypercalcemia of malignancy would be contraindicated as it could further increase calcium levels in the blood.
D) Hypophosphatemia: Calcitriol is not indicated for treating hypophosphatemia. In fact, administering calcitriol in hypophosphatemia can worsen the condition by increasing phosphate excretion in the urine.
Educational context: Understanding the indications for administering medications like calcitriol is crucial for healthcare professionals to ensure safe and effective patient care. Knowing when to use a medication and when not to can prevent adverse effects and optimize treatment outcomes. Being able to differentiate between various indications helps in making informed clinical decisions.
1,25-dihydroxyvitamin D3 (calcitriol) is the active form of vitamin D in the body. Administering calcitriol is indicated in cases of vitamin D resistance, where the body is unable to respond effectively to vitamin D. By providing the active form directly, the body can bypass the resistance and still utilize vitamin D for its various functions, such as calcium absorption in the gut and bone health.
Now, let's analyze why the other options are incorrect:
B) Elevated skeletal turnover: This is not an indication for administering calcitriol. Elevated skeletal turnover may be seen in conditions like osteoporosis, but calcitriol is not the primary treatment for this.
C) Hypercalcemia of malignancy: Administering calcitriol in hypercalcemia of malignancy would be contraindicated as it could further increase calcium levels in the blood.
D) Hypophosphatemia: Calcitriol is not indicated for treating hypophosphatemia. In fact, administering calcitriol in hypophosphatemia can worsen the condition by increasing phosphate excretion in the urine.
Educational context: Understanding the indications for administering medications like calcitriol is crucial for healthcare professionals to ensure safe and effective patient care. Knowing when to use a medication and when not to can prevent adverse effects and optimize treatment outcomes. Being able to differentiate between various indications helps in making informed clinical decisions.